enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Skin conditions in dogs: Symptoms, causes, and how to help - AOL

   www.aol.com/skin-conditions-dogs-symptoms-causes...

   The most common skin conditions in dogs 1. Skin allergies (atopic dermatitis) Skin allergies (atopic dermatitis) is a very common condition that affects up to 30% of dogs, ...

3. Dog skin disorders - Wikipedia

   en.wikipedia.org/wiki/Dog_skin_disorders

   Dog with atopic dermatitis, with signs around the eye created by rubbing. Atopy is a hereditary [3] and chronic (lifelong) allergic skin disease. Signs usually begin between 6 months and 3 years of age, with some breeds of dog, such as the golden retriever, showing signs at an earlier age. Dogs with atopic dermatitis are itchy, especially ...

4. US FDA approves Elanco's skin disease treatment for dogs - AOL

   www.aol.com/news/us-fda-approves-elancos-skin...

   The oral drug, Zenrelia, aims to control pruritus, or itching, associated with allergic dermatitis and to control atopic dermatitis in dogs that are at least 12 months old. Elanco considers ...

5. Dr. Cynthia Maro: Entering worst months for pet allergies - AOL

   www.aol.com/dr-cynthia-maro-entering-worst...

   Atopic dermatitis in dogs and cats is a condition that is characterized by itchy inflammation of the skin caused by an allergic response to multiple allergens. Veterinarians previously believed ...

6. Oclacitinib - Wikipedia

   en.wikipedia.org/wiki/Oclacitinib

   Oclacitinib, sold under the brand name Apoquel among others, is a veterinary medication used in the control of atopic dermatitis and pruritus from allergic dermatitis in dogs at least 12 months of age. [1] [4] Chemically, it is a synthetic cyclohexylamino pyrrolopyrimidine janus kinase inhibitor that is relatively selective for JAK1. [5]

7. Lokivetmab - Wikipedia

   en.wikipedia.org/wiki/Lokivetmab

   Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [2] which is a cytokine involved in causing itchiness (pruritus). [2] Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks. [3]